Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ye Ding

Showing results (341-350 of 369) with videos related to

Pageof 37
Sort By:
Lipids in Health and Disease|July 31, 2024
Interaction between antiretroviral therapy regimens and body mass index on triglyceride levels in people living with HIV: a cross-sectional and longitudinal studyYide Xu, Bufeng Qi, Xiaolu Wu, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 13, 2011
Tumor-specific silencing of COPZ2 gene encoding coatomer protein complex subunit ζ 2 renders tumor cells dependent on its paralogous gene COPZ1Michael Shtutman, Mirza Baig, Elina Levina, et al.
European Journal of Applied Physiology|February 29, 2012
Whole-body vibration and resistance exercise prevent long-term hindlimb unloading-induced bone loss: independent and interactive effectsZhili Li, Cheng Tan, Yonghua Wu, et al.
Oncotarget|June 4, 2015
Identification of novel genes that regulate androgen receptor signaling and growth of androgen-deprived prostate cancer cellsElina Levina, Hao Ji, Mengqiang Chen, et al.
Cell Death & Disease|June 8, 2026
Correction: Targeting 3-phosphoinositide-dependent protein kinase 1 associated with drug-resistant renal cell carcinoma using new oridonin analogsJiancheng Zhou, Eun-Jin Yun, Wei Chen, et al.
Cell Death & Disease|March 24, 2017
Targeting 3-phosphoinositide-dependent protein kinase 1 associated with drug-resistant renal cell carcinoma using new oridonin analogsJiancheng Zhou, Eun-Jin Yun, Wei Chen, et al.
BMC Cancer|May 26, 2023
CYD0281, a Bcl-2 BH4 domain antagonist, inhibits tumor angiogenesis and breast cancer tumor growthYihua Lin, Yiling Zhao, Minggui Chen, et al.
Magnetic Resonance in Medicine|April 3, 2023
Pushing the limits of low-cost ultra-low-field MRI by dual-acquisition deep learning 3D superresolutionVick Lau, Linfang Xiao, Yujiao Zhao, et al.
Nature Communications|January 11, 2019
Single-cell microRNA-mRNA co-sequencing reveals non-genetic heterogeneity and mechanisms of microRNA regulationNayi Wang, Ji Zheng, Zhuo Chen, et al.
Oncotarget|July 30, 2016
Targeting XBP1-mediated β-catenin expression associated with bladder cancer with newly synthetic Oridonin analoguesWei Chen, Jiancheng Zhou, Kaijie Wu, et al.
Pageof 37

Showing results (341-350 of 369) with videos related to

Sort By:
Pageof 37
Lipids in Health and Disease|July 31, 2024
Interaction between antiretroviral therapy regimens and body mass index on triglyceride levels in people living with HIV: a cross-sectional and longitudinal studyYide Xu, Bufeng Qi, Xiaolu Wu, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 13, 2011
Tumor-specific silencing of COPZ2 gene encoding coatomer protein complex subunit ζ 2 renders tumor cells dependent on its paralogous gene COPZ1Michael Shtutman, Mirza Baig, Elina Levina, et al.
European Journal of Applied Physiology|February 29, 2012
Whole-body vibration and resistance exercise prevent long-term hindlimb unloading-induced bone loss: independent and interactive effectsZhili Li, Cheng Tan, Yonghua Wu, et al.
Oncotarget|June 4, 2015
Identification of novel genes that regulate androgen receptor signaling and growth of androgen-deprived prostate cancer cellsElina Levina, Hao Ji, Mengqiang Chen, et al.
Cell Death & Disease|June 8, 2026
Correction: Targeting 3-phosphoinositide-dependent protein kinase 1 associated with drug-resistant renal cell carcinoma using new oridonin analogsJiancheng Zhou, Eun-Jin Yun, Wei Chen, et al.
Cell Death & Disease|March 24, 2017
Targeting 3-phosphoinositide-dependent protein kinase 1 associated with drug-resistant renal cell carcinoma using new oridonin analogsJiancheng Zhou, Eun-Jin Yun, Wei Chen, et al.
BMC Cancer|May 26, 2023
CYD0281, a Bcl-2 BH4 domain antagonist, inhibits tumor angiogenesis and breast cancer tumor growthYihua Lin, Yiling Zhao, Minggui Chen, et al.
Magnetic Resonance in Medicine|April 3, 2023
Pushing the limits of low-cost ultra-low-field MRI by dual-acquisition deep learning 3D superresolutionVick Lau, Linfang Xiao, Yujiao Zhao, et al.
Nature Communications|January 11, 2019
Single-cell microRNA-mRNA co-sequencing reveals non-genetic heterogeneity and mechanisms of microRNA regulationNayi Wang, Ji Zheng, Zhuo Chen, et al.
Oncotarget|July 30, 2016
Targeting XBP1-mediated β-catenin expression associated with bladder cancer with newly synthetic Oridonin analoguesWei Chen, Jiancheng Zhou, Kaijie Wu, et al.
Pageof 37